Voice treatment in Parkinson’s disease: patient perspectives

References

• Miller N, Allcock L, Jones D, Noble E, Hildreth A, Burn D. Prevalence and pattern of perceived intelligibility changes in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78(11):1188–1190.
   PubMed Web of Science ®Google Scholar
• Miller N, Noble E, Jones D, Deane KH, Gibb C. Survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: patients’ and carers’ perspectives. Int J Lang Commun Disord. 2011;46(2):179–188. doi:10.3109/13682822.2010.484850
   PubMed Web of Science ®Google Scholar
• Schalling E, Johansson K, Hartelius L. Speech and communication changes reported by people with Parkinson’s disease. Folia Phoniatrica Et Logopaedica. 2017;69(3):131–141. doi:10.1159/000479927
   PubMed Web of Science ®Google Scholar
• Rusz J, Cmejla R, Ruzickova H, Ruzicka E. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am. 2011;129(1):350–367. doi:10.1121/1.3514381
   PubMed Web of Science ®Google Scholar
• Miller N. Swallowing in Parkinson’s disease: clinical issues and management. Neurodegener Dis Manag. 2017;7(3):205–217. doi:10.2217/nmt-2017-0006
   Google Scholar
• Sapir S. Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J Speech Lang Hearing Res. 2014;57(4):1330–1343. doi:10.1044/2014_JSLHR-S-13-0039
   PubMed Web of Science ®Google Scholar
• Atkinson-Clement C, Sadat J, Pinto S. Behavioral treatments for speech in Parkinson’s disease: meta-analyses and review of the literature. Neurodegener Dis Manag. 2015;5(3):233–248. doi:10.2217/nmt.15.16
   PubMed Web of Science ®Google Scholar
• Dashtipour K, Tafreshi A, Lee J, Crawley B. Speech disorders in Parkinson’s disease: pathophysiology, medical management and surgical approaches. Neurodegener Dis Manag. 2018;8(5):337–348. doi:10.2217/nmt-2018-0021
   Web of Science ®Google Scholar
• Miller N, Allcock L, Jones D, Noble E, Hildreth AJ, Burn DJ. Prevalence and pattern of perceived intelligibility changes in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78(11):1188–1190. doi:10.1136/jnnp.2006.110171
   PubMed Web of Science ®Google Scholar
• Miller N, Noble E, Jones D, Deane KHO, Gibb C. Survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: patients’ and carers’ perspectives. Int J Lang Commun Disord. 2011;46(2):179–188.
   PubMed Web of Science ®Google Scholar
• Miller N. Communication changes in Parkinson’s disease. Pract Neurol. 2017;17(4):266–274. doi:10.1136/practneurol-2017-001635
   PubMedGoogle Scholar
• Gruszka A, Hampshire A, Barker RA, Owen AM. Normal aging and Parkinson’s disease are associated with the functional decline of distinct frontal-striatal circuits. Cortex. 2017;93:178–192. doi:10.1016/j.cortex.2017.05.020
   PubMed Web of Science ®Google Scholar
• Mollaei F, Shiller DM, Baum SR, Gracco VL. Sensorimotor control of vocal pitch and formant frequencies in Parkinson’s disease. Brain Res. 2016;1646:269–277. doi:10.1016/j.brainres.2016.06.013
   Web of Science ®Google Scholar
• New AB, Robin DA, Parkinson AL, et al. The intrinsic resting state voice network in Parkinson’s disease. Hum Brain Mapp. 2015;36(5):1951–1962. doi:10.1002/hbm.22748
   PubMed Web of Science ®Google Scholar
• Read J, Miller N, Kitsou N. Is there an order of loss of sounds in speakers with Parkinson’s disease? Clin Linguist Phon. 2018;32(11):997–1011. doi:10.1080/02699206.2018.1504989
   PubMed Web of Science ®Google Scholar
• Martens H, Van Nuffelen G, Wouters K, De Bodt M. Reception of communicative functions of prosody in hypokinetic dysarthria due to Parkinson’s disease. J Parkinson’s Dis. 2016;6(1):219–229. doi:10.3233/JPD-150678
   PubMedGoogle Scholar
• Brajot FX, Shiller DM, Gracco VL. Autophonic loudness perception in Parkinson’s disease. J Acoust Soc Am. 2016;139(3):1364–1371. doi:10.1121/1.4944569
   Web of Science ®Google Scholar
• Iddon H, Read J, Miller N. Does voice amplification increase intelligibility in people with Parkinson’s disease? Int J Ther Rehabil. 2015;22(10):479–486. doi:10.12968/ijtr.2015.22.10.479
   Google Scholar
• Neel AT. Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease. J Speech Lang Hear Res. 2009;52(4):1021–1033. doi:10.1044/1092-4388(2008/08-0119)
   PubMed Web of Science ®Google Scholar
• Bocanegra Y, García AM, Pineda D, et al. Syntax, action verbs, action semantics, and object semantics in Parkinson’s disease: dissociability, progression, and executive influences. Cortex. 2015;69:237–254. doi:10.1016/j.cortex.2015.05.022
   PubMed Web of Science ®Google Scholar
• Walsh B, Smith A. Linguistic complexity, speech production, and comprehension in Parkinson’s disease: behavioral and physiological indices. J Speech Lang Hear Res. 2011;54(3):787–802. doi:10.1044/1092-4388(2010/09-0085)
   PubMed Web of Science ®Google Scholar
• MacPherson MK, Huber JE, Snow DP. The intonation-syntax interface in the speech of individuals with Parkinson’s disease. J Speech Lang Hear Res. 2011;54(1):19–32. doi:10.1044/1092-4388(2010/09-0079)
   PubMed Web of Science ®Google Scholar
• De Keyser K, Santens P, Bockstael A, et al. The relationship between speech production and speech perception deficits in Parkinson’s disease. J Speech Lang Hearing Res. 2016;59(5):915–931. doi:10.1044/2016_JSLHR-S-15-0197
   Web of Science ®Google Scholar
• Albuquerque L, Martins M, Coelho M, et al. Advanced Parkinson disease patients have impairment in prosody processing. J Clin Exp Neuropsychol. 2016;38(2):208–216. doi:10.1080/13803395.2015.1100279
   PubMed Web of Science ®Google Scholar
• Kwan LC, Whitehill TL. Perception of speech by individuals with Parkinson’s disease: a review. Parkinson’s Dis. 2011;2011:389767. doi:10.4061/2011/153979
   PubMedGoogle Scholar
• Pell MD, Monetta L, Rothermich K, Kotz SA, Cheang HS, McDonald S. Social perception in adults with Parkinson’s disease. Neuropsychology. 2014;28(6):905–916. doi:10.1037/neu0000090
   PubMed Web of Science ®Google Scholar
• Miller N, Noble E, Jones D, Burn D. Life with communication changes in Parkinson’s disease. Age Ageing. 2006;35(3):235–239. doi:10.1093/ageing/afj053
   PubMed Web of Science ®Google Scholar
• Walshe M, Miller N, Leahy M, Murray A. Intelligibility of dysarthric speech: perceptions of speakers and listeners. Int J Lang Commun Disord. 2008;43(6):633–648. doi:10.1080/13682820801887117
   PubMed Web of Science ®Google Scholar
• Miller N, Andrew S, Noble E, Walshe M. Changing perceptions of self as a communicator in Parkinson’s disease: a longitudinal follow-up study. Disabil Rehabil. 2011;33(3):204–210. doi:10.3109/09638288.2010.508099
   PubMed Web of Science ®Google Scholar
• Miller N, Noble E, Jones D, Allcock L, Burn DJ. How do I sound to me? Perceived changes in communication in Parkinson’s disease. Clin Rehabil. 2008;22(1):14–22. doi:10.1177/0269215507079096
   PubMed Web of Science ®Google Scholar
• Saldert C, Ferm U, Bloch S. Semantic trouble sources and their repair in conversations affected by Parkinson’s disease. Int J Lang Commun Disord. 2014;49(6):710–721. doi:10.1111/1460-6984.12105
   PubMed Web of Science ®Google Scholar
• McAuliffe M, Baylor C, Yorkston K. Variables associated with communicative participation in Parkinson’s disease and its relationship to measures of health-related quality-of-life. Int J Speech Lang Pathol. 2017;19(4):407–417. doi:10.1080/17549507.2016.1193900
   PubMed Web of Science ®Google Scholar
• Whitehead B. The psychosocial impact of communication changes in people with Parkinson’s disease. Br J Neurosci Nurs. 2010;6(1):30–36. doi:10.12968/bjnn.2010.6.1.46056
   Google Scholar
• Hartelius L, Miller N. The ICF framework and its relevance to the assessment of people with motor speech disorders. In: Lowit A, Kent R, editors. Assessment of Motor Speech Disorders. San Diego: Plural; 2010;1:1–20.
   Google Scholar
• Kim HA, Kim SW, Yoon JH. Comparison between self-reported and objective measures on speech characteristics in patients with Parkinson’s disease. Commun Sci Disord-Csd. 2018;23(1):228–241. doi:10.12963/csd.17453
   Google Scholar
• Dykstra AD, Adams SG, Jog M. Examining the relationship between speech intensity and self-rated communicative effectiveness in individuals with Parkinson’s disease and hypophonia. J Commun Disord. 2015;56:103–112. doi:10.1016/j.jcomdis.2015.06.012
   PubMed Web of Science ®Google Scholar
• Skodda S, Grönheit W, Schlegel U. Intonation and speech rate in Parkinson’s disease: general and dynamic aspects and responsiveness to levodopa admission. J Voice. 2011;25(4):e199–e205. doi:10.1016/j.jvoice.2010.04.007
   PubMed Web of Science ®Google Scholar
• Motta S, Cesari U, Paternoster M, Motta G, Orefice G. Aerodynamic findings and voice handicap index in Parkinson’s disease. Eur Arch Oto-Rhino-Laryn. 2018;275(6):1569–1577. doi:10.1007/s00405-018-4967-7
   Web of Science ®Google Scholar
• Ma JKY, Schneider CB, Hoffmann R, Storch A. Speech prosody across stimulus types for individuals with Parkinson’s disease. J Parkinson’s Dis. 2015;5(2):291–299. doi:10.3233/JPD-140451
   Google Scholar
• Elfmarková N, Gajdoš M, Mračková M, Mekyska J, Mikl M, Rektorová I. Impact of Parkinson’s disease and levodopa on resting state functional connectivity related to speech prosody control. Parkinsonism Relat Disord. 2016;22(Supplement 1):S52–S55. doi:10.1016/j.parkreldis.2015.09.006
   Google Scholar
• Galaz Z, Mekyska J, Mzourek Z, et al. Prosodic analysis of neutral, stress-modified and rhymed speech in patients with Parkinson’s disease. Comput Methods Programs Biomed. 2016;127:301–317. doi:10.1016/j.cmpb.2015.12.011
   Web of Science ®Google Scholar
• Lyons K, Tickle-Degnen L, DeGroat E. Inferring personality traits of clients with Parkinson’s disease from their descriptions of favourite activities. Clin Rehabil. 2005;19(7):799–809. doi:10.1191/0269215505cr897oa
   Web of Science ®Google Scholar
• Jaywant A, Pell M. Listener impressions of speakers with Parkinson’s disease. J Int Neuropsychol Soc. 2010;16(1):49–57. doi:10.1017/S1355617709990919
   PubMed Web of Science ®Google Scholar
• Balash Y, Korczyn A, Knaani J, Migirov A, Gurevich T. Quality-of-life perception by Parkinson’s disease patients and caregivers. Acta Neurol Scand. 2017;136(2):151–154. doi:10.1111/ane.12726
   PubMed Web of Science ®Google Scholar
• Gunnery SD, Habermann B, Saint-Hilaire M, Thomas CA, Tickle-Degnen L. The relationship between the experience of hypomimia and social wellbeing in people with Parkinson’s disease and their care partners. J Parkinson’s Dis. 2016;6(3):625–630. doi:10.3233/JPD-160782
   Google Scholar
• Bandini A, Orlandi S, Escalante HJ, et al. Analysis of facial expressions in parkinson’s disease through video-based automatic methods. J Neurosci Methods. 2017;281:7–20. doi:10.1016/j.jneumeth.2017.02.006
   PubMed Web of Science ®Google Scholar
• Holmes JD, Jenkins ME, Johnson AM, Adams SG, Spaulding SJ. Dual-task interference: the effects of verbal cognitive tasks on upright postural stability in Parkinson’s disease. Parkinson’s Dis. 2010;2010:696492.
   PubMed Web of Science ®Google Scholar
• Llamas C, Watt D, editors. Language and Identities. Edinburgh: Edinburgh University Press; 2010.
   Google Scholar
• Miller N, Taylor J, Howe C, Read J. Living with foreign accent syndrome: insider perspectives. Aphasiology. 2011;25(9):1053–1068. doi:10.1080/02687038.2011.573857
   Web of Science ®Google Scholar
• Walshe M, Miller N. Living with acquired dysarthria: the speaker’s perspective. Disability Rehabil. 2011;33(3):195–203. doi:10.3109/09638288.2010.511685
   PubMed Web of Science ®Google Scholar
• Lawson RA, Collerton D, Taylor J-P, Burn D, Brittain K. Coping with cognitive impairment in people with Parkinson’s disease and their carers: a qualitative study. Parkinson’s Dis. 2018;2018:1–10. Article ID 1362053. doi:10.1155/2018/1362053.:10
   Web of Science ®Google Scholar
• Cleary PD. Evolving concepts of patient-centered care and the assessment of patient care experiences: optimism and opposition. J Health Politics Policy Law. 2016;41(4):675–696. doi:10.1215/03616878-3620881
   PubMed Web of Science ®Google Scholar
• Walshe M, Peach R, Miller N. Dysarthria impact profile: development of a scale to measure psychosocial effects. Int J Lang Commun Disord. 2009;44(5):693–715. doi:10.1080/13682820802317536
   PubMed Web of Science ®Google Scholar
• Miller N, Deane KH, Jones D, Noble E, Gibb C. National survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: therapists’ practices. Int J Lang Commun Disord. 2011;46(2):189–201. doi:10.3109/13682822.2010.484849
   PubMed Web of Science ®Google Scholar
• Yorkston K, Baylor C, Britton D. Speech versus speaking: the experiences of people with Parkinson’s disease and implications for intervention. Am J Speech Lang Pathol. 2017;26(2S):561–568. doi:10.1044/2017_AJSLP-16-0087
   PubMedGoogle Scholar
• Spurgeon L, Clarke CE, Sackley C. Subjective experiences of speech and language therapy in patients with Parkinson’s disease: a pilot study. Rehabil Res Pract. 2015;2015:1–11. [Erratum appears in Rehabil Res Pract. 2016;1654282; PMID: 27630774]. doi:10.1155/2015/839895
   Google Scholar
• Tjaden K, Lam J, Wilding G. Vowel acoustics in Parkinson’s disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions. J Speech Lang Hear Res. 2013;56(5):1485–1502. doi:10.1044/1092-4388(2013/12-0259)
   PubMed Web of Science ®Google Scholar
• Anand S, Stepp C. Listener perception of monopitch, naturalness, and intelligibility for speakers with Parkinson’s disease. J Speech Lang Hearing Res. 2015;58(4):1134–1144. doi:10.1044/2015_JSLHR-S-14-0243
   PubMed Web of Science ®Google Scholar
• Halpern A, Ramig L, Matos C, et al. Innovative technology for the assisted delivery of intensive voice treatment (LSVTLOUD) for Parkinson disease. Am J Speech Lang Pathol. 2012;21(4):354–367. doi:10.1044/1058-0360(2012/11-0125)
   PubMed Web of Science ®Google Scholar
• Wight S, Miller N. Lee silverman voice treatment for people with Parkinson’s: audit of outcomes in a routine clinic. Int J Lang Commun Disord. 2015;50(2):215–225. doi:10.1111/1460-6984.12132
   Web of Science ®Google Scholar
• Moya-Galé G, Goudarzi A, Bayés A, McAuliffe M, Bulté B, Levy E. The effects of intensive speech treatment on conversational intelligibility in Spanish speakers with Parkinson’s disease. Am J Speech Lang Pathol. 2018;27(1):154–165. doi:10.1044/2017_AJSLP-17-0032
   Web of Science ®Google Scholar
• Ramig L, Halpern A, Spielman J, Fox C, Freeman K. Speech treatment in Parkinson’s disease: randomized controlled trial (RCT). Mov Disord. 2018;33(11):1777–1791. doi:10.1002/mds.27460
   PubMed Web of Science ®Google Scholar
• Dias A, Limongi J, Barbosa E, Hsing W. Voice telerehabilitation in Parkinson’s disease. CoDAS. 2016;28(2):176–181. doi:10.1590/2317-1782/20162015161
   Google Scholar
• Simberg S, Rae J, Kallvik E, Salo B, Martikainen K. Effects of speech therapy on voice and speech in Parkinson’s after a 15-day rehabilitation course: a pilot study. Int J Ther Rehabil. 2012;19(5):273–285. doi:10.12968/ijtr.2012.19.5.273
   Google Scholar
• Searl J, Wilson K, Haring K, Dietsch A, Lyons K, Pahwa R. Feasibility of group voice therapy for individuals with Parkinson’s disease. J Commun Disord. 2011;44(6):719–732. doi:10.1016/j.jcomdis.2011.05.001
   PubMed Web of Science ®Google Scholar
• Elefant C, Baker FA, Lotan M, Lagesen SK, Skeie GO. The effect of group music therapy on mood, speech, and singing in individuals with Parkinson’s disease–a feasibility study. J Music Ther. 2012;49(3):278–302.
   PubMed Web of Science ®Google Scholar
• Shih LC, Piel J, Warren A, et al. Singing in groups for Parkinson’s disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders. Parkinsonism Relat Disord. 2012;18(5):548–552. doi:10.1016/j.parkreldis.2012.02.009
   PubMed Web of Science ®Google Scholar
• Stegemöller E, Radig H, Hibbing P, Wingate J, Sapienza C. Effects of singing on voice, respiratory control and quality of life in persons with Parkinson’s disease. Disabil Rehabil. 2017;39(6):594–600. doi:10.3109/09638288.2016.1152610
   PubMed Web of Science ®Google Scholar
• Jacobson B, Johnson A, Grywalski C, et al. The Voice Handicap Index (VHI). Am J Speech Lang Pathol. 1997;6(3):66–70. doi:10.1044/1058-0360.0603.66
   Google Scholar
• Ma EP, Yiu EML. Voice activity and participation profile. J Speech Lang Hearing Res. 2001;44(3):511–524. doi:10.1044/1092-4388(2001/040)
   PubMed Web of Science ®Google Scholar
• Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice. 1999;13(4):557–569.
   PubMed Web of Science ®Google Scholar
• Donovan N, Kendall D, Young M, Rosenbek J. The communicative effectiveness survey: preliminary evidence of construct validity. Am J Speech Lang Pathol. 2008;17:335–347. doi:10.1044/1058-0360(2008/07-0010)
   PubMed Web of Science ®Google Scholar
• Baylor C, McAuliffe M, Hughes Louise E, et al. A Differential Item Functioning (DIF) Analysis of the Communicative Participation Item Bank (CPIB): comparing individuals with Parkinson’s disease from the United States and New Zealand. J Speech Lang Hearing Res. 2014;57(1):90–95. doi:10.1044/1092-4388(2013/12-0414)
   PubMed Web of Science ®Google Scholar
• Sackley C, Smith C, Rick C, et al. Lee silverman voice treatment versus standard speech and language therapy versus control in Parkinson’s disease: a pilot randomised controlled trial (PD COMM pilot). Pilot Feasibility Stud. 2018;4(1):30. doi:10.1186/s40814-017-0222-z
   Google Scholar
• Oxford Centre for Evidence-Based Medicine. Levels of Evidence. University of Oxford; 2011. Available from: http://www.cebm.net. Accessed March 02, 2019.
   Google Scholar
• World Health Organisation. 2001 International Classification of Functioning, Disability and Health (ICF). Geneva,Switzerland.
   Google Scholar
• Baylor C, Yorkston K, Eadie T, Kim J, Chung H, Amtmann D. The Communicative Participation Item Bank (CPIB): item bank calibration and development of a disorder-generic short form. J Speech Lang Hearing Res. 2013;56(4):1190–1208. doi:10.1044/1092-4388(2012/12-0140)
   PubMed Web of Science ®Google Scholar
• Stegemöller EL, Hurt TR, O’Connor MC, et al. Experiences of persons with Parkinson’s disease engaged in group therapeutic singing. J Music Ther. 2017;54(4):405–431. doi:10.1093/jmt/thx012
   Web of Science ®Google Scholar